Your browser doesn't support javascript.
loading
Vitexin attenuates autoimmune hepatitis in mouse induced by syngeneic liver cytosolic proteins via activation of AMPK/AKT/GSK-3ß/Nrf2 pathway.
Zhang, Lei; Chen, Dazhi; Tu, Yulu; Sang, Tiantian; Pan, Tongtong; Lin, Hongwei; Cai, Chao; Jin, Xiaozhi; Wu, Faling; Xu, Lanman; Chen, Yongping.
Affiliation
  • Zhang L; Department of Infectious Diseases, The First Affiliated Hospital of Wenzhou Medical University, Zhejiang Provincial Key Laboratory for Accurate Diagnosis and Treatment of Chronic Liver Diseases, Wenzhou Key Laboratory of Hepatology, Hepatology Institute of Wenzhou Medical University, Wenzhou, 325006
  • Chen D; Department of Gastroenterology, The First Hospital of Peking University, BeiJing, 100032, China.
  • Tu Y; Department of Gastroenterology, Ningbo Hangzhou Bay Hospital, Ningbo, 315336, Zhejiang, China.
  • Sang T; School of Laboratory Medicine and Life Science, Wenzhou Medical University, Wenzhou, 325006, China.
  • Pan T; Department of Infectious Diseases, The First Affiliated Hospital of Wenzhou Medical University, Zhejiang Provincial Key Laboratory for Accurate Diagnosis and Treatment of Chronic Liver Diseases, Wenzhou Key Laboratory of Hepatology, Hepatology Institute of Wenzhou Medical University, Wenzhou, 325006
  • Lin H; Department of Infectious Diseases, The First Affiliated Hospital of Wenzhou Medical University, Zhejiang Provincial Key Laboratory for Accurate Diagnosis and Treatment of Chronic Liver Diseases, Wenzhou Key Laboratory of Hepatology, Hepatology Institute of Wenzhou Medical University, Wenzhou, 325006
  • Cai C; Department of Infectious Diseases, The First Affiliated Hospital of Wenzhou Medical University, Zhejiang Provincial Key Laboratory for Accurate Diagnosis and Treatment of Chronic Liver Diseases, Wenzhou Key Laboratory of Hepatology, Hepatology Institute of Wenzhou Medical University, Wenzhou, 325006
  • Jin X; Department of Infectious Diseases, The First Affiliated Hospital of Wenzhou Medical University, Zhejiang Provincial Key Laboratory for Accurate Diagnosis and Treatment of Chronic Liver Diseases, Wenzhou Key Laboratory of Hepatology, Hepatology Institute of Wenzhou Medical University, Wenzhou, 325006
  • Wu F; Department of Infectious Diseases, The First Affiliated Hospital of Wenzhou Medical University, Zhejiang Provincial Key Laboratory for Accurate Diagnosis and Treatment of Chronic Liver Diseases, Wenzhou Key Laboratory of Hepatology, Hepatology Institute of Wenzhou Medical University, Wenzhou, 325006
  • Xu L; Department of Infectious Diseases and Liver Diseases, Ningbo Medical Center Lihuili Hospital, Affiliated Hospital of Ningbo University, Ningbo, 315040, Zhejiang, China. Electronic address: 13587646315@163.com.
  • Chen Y; Department of Infectious Diseases, The First Affiliated Hospital of Wenzhou Medical University, Zhejiang Provincial Key Laboratory for Accurate Diagnosis and Treatment of Chronic Liver Diseases, Wenzhou Key Laboratory of Hepatology, Hepatology Institute of Wenzhou Medical University, Wenzhou, 325006
Eur J Pharmacol ; 917: 174720, 2022 Feb 15.
Article de En | MEDLINE | ID: mdl-34953801
Sujet(s)
Mots clés
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Facteur-2 apparenté à NF-E2 Type d'étude: Prognostic_studies Langue: En Journal: Eur J Pharmacol Année: 2022 Type de document: Article Pays de publication: Pays-Bas
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Facteur-2 apparenté à NF-E2 Type d'étude: Prognostic_studies Langue: En Journal: Eur J Pharmacol Année: 2022 Type de document: Article Pays de publication: Pays-Bas